“… bezafibrate lowered plasma C (-14%) … VLDL lipids (-37% for C , -56% for TG and -25% for PL), raising VLDL C/TG ratio (+46%), redistributing TG from VLDL to LDL (+10%) … B levels and increased HDL-C together with Apo A1 (+19% and +13%) and Apo A1/Apo B (+72%).”